CAS: 113952-21-9; 5-Carbamoyl-10,11-Dihydro-11-Oxo-5H-Dibenzazepine-10-Yl Acetate

该化合物是属于苯并类的化学化合物,其特点是有苯并苯和环结构.该化合物是一个碳胺基组和一个乙酰基组,有助于其潜在的生物活动.碳基和氨基功能的存在表明,它可能表现出氢联结和潜在再活动等特性.其结构复杂性可能会影响其溶性,稳定性和与生物目标的相互作用,使其对医药化学具有兴趣.这种性质的化合物往往因其药用特性而受到调查,包括可能被用于治疗...

结构式图片

MSDS等安全信息

    上下游产品

    potassium acetate oxcarbazepine [bis(acetoxy)iodo]benzene azepine-5-carboxamidecis-10,11-dihydro-10,11-dihydroxy-5H-dibenzazepine-5-carboxamide azepine-5-carboxamidetrans-10,11-dihydro-10,11-dihydroxy-5H-dibenzazepine-5-carboxamide

    合成工艺路线路线简述

      📜奥卡西平,碘苯二乙酸置于溶剂黄146体系中,化学反应 16.0H,以27%的收率获得10-乙酰氧基奥卡西平
      参考文献:Complementation Of Biotransformations With Chemical C-h Oxidation: Copper-Catalyzed Oxidation Of Tertiary Amines In Complex Pharmaceuticals
      标题:Complementation Of Biotransformations With Chemical C-h Oxidation: Copper-Catalyzed Oxidation Of Tertiary Amines In Complex Pharmaceuticals
      摘要:The Isolation,Quantitation,And Characterization Of Drug Metabolites In Biological Fluids Remain Challenging. Rapid Access To Oxidized Drugs Could Facilitate Metabolite Identification And Enable Early Pharmacology And Toxicity Studies. Herein,We Compared Biotransformations To Classical And New Chemical C-H Oxidation Methods Using Oxcarbazepine,Naproxen,And An Early Compound Hit (Phthalazine 1). These Studies Illustrated The Low Preparative Efficacy Of Biotransformations And The Inability Of Chemical Methods To Oxidize Complex Pharmaceuticals. We Also Disclose An Aerobic Catalytic Protocole (Cui/air) To Oxidize Tertiary Amines And Benzylic Ch'S In Drugs. The Reaction Tolerates A Broad Range Of Functionalities And Displays A High Level Of Chemoselectivity,Which Is Not Generally Explained By The Strength Of The C-H Bonds But By The Individual Structural Chemotype. This Study Represents A First Step Toward Establishing A Chemical Toolkit (Chemotransformations) That Can Selectively Oxidize C-H Bonds In Complex Pharmaceuticals And Rapidly Deliver Drug Metabolites.
      Doi:10.1021/ja405471H

      海关参考信息

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      合成参考文献

      参考DOI号:10.1002/hlca.19870700730
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知